UTTERTX
Live / Allowed — Second extension granted (statement of use) (as of 13 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 May 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98549415
- Mark type
- Word mark
- Filed
- 14 May 2024
- Published for opposition
- 18 Mar 2025
- Attorney of record
- Gregg R Sultan
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products in the nature of preparations, treatment preparations and medicines for treating cancer and autoimmune diseases
Owner
- Utter Therapeutics Inc., San Francisco, CA, US
- Utter Therapeutics Inc., San Francisco, CA, US
Prosecution history
- 14 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 May 2026 — SOU EXTENSION 2 GRANTED
- 13 May 2026 — SOU EXTENSION 2 FILED
- 13 May 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Nov 2025 — SOU EXTENSION 1 GRANTED
- 13 Nov 2025 — SOU EXTENSION 1 FILED
- 13 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 13 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Mar 2025 — PUBLISHED FOR OPPOSITION
- 12 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE